RVMD
Revolution Medicines Inc Earnings
$44.71
Earnings Summary
Revenue | $0Mn |
Net Profits | $-247.79Mn |
Net Profit Margins | -Inf% |
Revolution Medicines Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its revenue since last 3-months.
Revolution Medicines Inc’s net profit fell -85.98% since last year same period to $-247.79Mn in the Q2 2025. On a quarterly growth basis, Revolution Medicines Inc has generated -16.11% fall in its net profits since last 3-months.
Revolution Medicines Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.41 |
EPS Estimate Current Year | -1.41 |
Revolution Medicines Inc’s earning per share (EPS) estimates for the current quarter stand at -1.41 - a -25.89% fall from last quarter’s estimates.
Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -1.41.
Key Ratios
Earning Per Share (EPS) | 0 |
Revolution Medicines Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Revolution Medicines Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-07 | -0.75 | -1.13 | -50.67% |
2025-08-06 | -1.12 | -1.31 | -16.96% |
2025-11-05 | -1.41 | 0 | 100% |
